sutimlimab
EHA21: Sanofi builds case for rare disease drug sutimlimab after FDA rejection
Phil Taylor
cold agglutinin disease, EHA 2021, Haematology, rare disease, Sanofi, sutimlimab
0 Comment
X
EHA21: Sanofi builds case for rare disease drug sutimlimab after FDA rejection
https://pharmaphorum.com/news/eha21-sanofi-builds-case-for-rare-disease-drug-sutimlimab-after-fda-rejection/